ArticleMolecular pharmaceutics2021

Targeting Triple Negative Breast Cancer with a Nucleus-Directed p53 Tetramerization Domain Peptide.

Gu Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.